These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12461788)

  • 61. p21ras independent down-regulation of ras-induced increases in natural antibody binding during tumor progression.
    Tough DF; Feng X; Chow DA
    Nat Immun; 1995; 14(1):20-34. PubMed ID: 7599459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transfection of EK-3, a subline of NIH 3T3, with the oncogene Ha-ras does not abolish its anchorage dependence.
    Katz E; Samid D
    Eur J Cell Biol; 1989 Aug; 49(2):221-4. PubMed ID: 2673787
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transcription factor ATF3 partially transforms chick embryo fibroblasts by promoting growth factor-independent proliferation.
    Perez S; Vial E; van Dam H; Castellazzi M
    Oncogene; 2001 Mar; 20(9):1135-41. PubMed ID: 11314051
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transformation by ras modifies AP1 composition and activity.
    Mechta F; Lallemand D; Pfarr CM; Yaniv M
    Oncogene; 1997 Feb; 14(7):837-47. PubMed ID: 9047391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.
    Woessner RD; Chung TD; Hofmann GA; Mattern MR; Mirabelli CK; Drake FH; Johnson RK
    Cancer Res; 1990 May; 50(10):2901-8. PubMed ID: 2159365
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.
    Podo F; Ferretti A; Knijn A; Zhang P; Ramoni C; Barletta B; Pini C; Baccarini S; Pulciani S
    Anticancer Res; 1996; 16(3B):1399-412. PubMed ID: 8694508
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ras(leu61) blocks differentiation of transformable 3T3 L1 and C3H10T1/2-derived preadipocytes in a dose- and time-dependent manner.
    Raptis L; Yang J; Brownell H; Lai J; Preston T; Corbley MJ; Narsimhan RP; Haliotis T
    Cell Growth Differ; 1997 Jan; 8(1):11-21. PubMed ID: 8993830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evidence for the transforming activity of a truncated Int6 gene, in vitro.
    Rasmussen SB; Kordon E; Callahan R; Smith GH
    Oncogene; 2001 Aug; 20(38):5291-301. PubMed ID: 11536042
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transcriptional inhibition of Ha-ras in interferon-induced revertants of ras-transformed mouse cells.
    Rimoldi D; Samid D; Flessate DM; Friedman RM
    Cancer Res; 1988 Sep; 48(18):5157-62. PubMed ID: 2457435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differentiation can convey resistance to transformation by activated ras oncogene.
    Tzen CY; Maercklein PB; Scott RE
    Anticancer Res; 1990; 10(5A):1329-34. PubMed ID: 2241110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Codeletion of the JUN proto-oncogene and the CDKN2A tumor-suppressor gene in HRAS-transformed rat embryo fibroblast cell lines.
    Zhou JN; Ljungdahl S; Röhme D; Levan G; Shoshan MC; Linder S
    Genes Chromosomes Cancer; 1997 Sep; 20(1):82-9. PubMed ID: 9290958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An analysis of an interactome for apoptosis factor, Ei24/PIG8, using the inducible expression system and shotgun proteomics.
    Bahk YY; Lee J; Cho IH; Lee HW
    J Proteome Res; 2010 Oct; 9(10):5270-83. PubMed ID: 20731388
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
    Esteve P; del Peso L; Lacal JC
    Oncogene; 1995 Dec; 11(12):2657-65. PubMed ID: 8545123
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Elevated prostaglandin H synthase gene expression in ras-transformed cells.
    Gorman RR; Bienkowski MJ; Lin AH
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():73-6. PubMed ID: 1825590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein.
    Xin H; D'Souza S; Fang L; Lengyel P; Choubey D
    Oncogene; 2001 Oct; 20(47):6828-39. PubMed ID: 11687962
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The H-ras oncogene interferes with retinoic acid signaling and metabolism in NIH3T3 cells.
    Kósa K; Jones CS; De Luca LM
    Cancer Res; 1995 Nov; 55(21):4850-4. PubMed ID: 7585519
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reduced protein kinase C activity in a ras-resistant cell line derived from Ki-MSV transformed cells.
    Kamata T; Sullivan NF; Wooten MW
    Oncogene; 1987 Mar; 1(1):37-46. PubMed ID: 2830575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.
    Mello ML; Contente S; Vidal BC; Planding W; Schenck U
    Exp Cell Res; 1995 Oct; 220(2):374-82. PubMed ID: 7556446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.